LTB4-IN-1 is primarily used in research settings to study its effects on inflammation and immune responses. It acts as an inhibitor of leukotriene B4 (LTB4), a molecule involved in inflammatory processes. By blocking LTB4, it helps researchers understand the role of this pathway in diseases like asthma, arthritis, and other inflammatory conditions. It is also utilized in preclinical studies to evaluate its potential as a therapeutic agent for treating inflammatory disorders. Additionally, it aids in exploring the mechanisms of LTB4 in cellular signaling and its impact on immune cell function.